Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2025-12-25 @ 4:52 AM
NCT ID:
NCT04380818
Eligibility Criteria:
Inclusion Criteria:
* Age \>=18 years old
* Moderate to severe COVID-19 pneumonia with fewer than 8 days of symptom onset and currently receiving standard medication for COVID-19 at appropriate doses
* PAFIO2 of less than 300 mmHg or SaFI02 \<315 mmHg
* Patients who are not candidates for admission to the Intensive Care Unit due to age, concomitant diseases or general condition.
* One of the following conditions:
* or IL6 greater than 40
* or PCR\> 100mg / l
* D-dimer greater than 1500ng / ml
* Suspected cytokine release syndrome
* Have read the information sheet and signed the informed consent
Exclusion Criteria:
* Age \<18 years
* Failure to meet the inclusion criteria
* Leukopenia \<1000
* Pregnancy
* Not understanding or refusing the purpose of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT04380818
Study Brief:
Protocol Section:
NCT04380818